The leader in the business of psychedelics, Microdose is taking the next step in industry events with Wonderland: Miami. Wonderland will take place November 8-9, 2021 at the beautiful Adrienne Arsht Center for the Performing Arts in downtown Miami. The event will be the industry’s largest ever in-person event, with over 2,000 attendees and an impressive line-up of industry researchers, investors, journalists, and CEOs.
Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine industry. So it’s an honor for Microdose to announce our line-up of sponsors for Wonderland: Miami
Headline Sponsor
H.C. Wainwright & Co., LLC (HCW) is a full-service, research-driven, and equity capital markets-focused investment bank, which specializes in capital markets solutions for middle-market companies worldwide. HCW has one of the largest equity research footprints in the Life Sciences & Healthcare industry with coverage on over 580 companies by 50 research professionals. According to Sagient Research Systems, the firm has been the leader in the CMPO (confidentially marketed public offering), RD (registered direct offering) and PIPE (private investment in public equity) transaction markets since 1998. Year-to-date 2021, HCW has executed over 300 transactions with nearly $20bn transaction value. The HCW team is comprised of over 100 professionals, including 12 Ph.D.’s across investment banking and equity research. HCW is dedicated to facilitating corporate access, with over 300 non-deal roadshows annually and 850+ companies having presented at our 2021 Annual Investor Conference
Platinum Sponsors
Alvarius Pharmaceuticals, a biopharmaceutical company headquartered in Ireland, was founded by psychedelic and plant medicine expert Dr. James Linden. We are performing cutting-edge research into the anti-addiction properties of 5-MeO-DMT and developing treatments that utilize the power of psychedelics to empower patients toward a life free from substance dependency. With our in-house scientific, research and clinical expertise, we are proud to be at the precipice of harnessing the true healing potential of safe, natural psychedelics, and are honored to be at the vanguard of establishing these incredible substances as widely used treatments in mental health.
Numinus Wellness helps people heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – combining psychedelic production, research and clinical care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain, and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Wake Network is developing integrative psychedelic experiences by combining breakthrough research on human genetics, natural psilocybin, and traditional healing methods. Founded in 2019, Wake has been focused on the production of psilocybin mushrooms from its Mandeville Jamaica production facility while utilizing the latest in wearable technology and biomarker data collection to inform precision medicine integration in both microdose and macrodose drug delivery.
Mindset Pharma is a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines. The Company has developed a robust pipeline of new optimized psychedelic drugs that have been designed to better meet the needs of patients by addressing some of the shortcomings of the known psychedelics. The Company is led by a highly experienced team with significant expertise in medicinal chemistry, behavioral pharmacology, and drug discovery and development. To date, Mindset has identified four distinct families of novel psychedelic medicines and is progressing them towards clinical trials.
Wesana Health is an emerging life sciences company championing the development of innovative approaches for better understanding, protecting and improving neurological health and performance. Through extensive clinical research and academic partnerships, Wesana Health is developing evidence-based formulations and protocols, including psilocybin-based therapies, that empower patients to overcome neurological, psychological and mental health ailments. Learn more at www.wesanahealth.com
Gold Sponsors
Nue Life is a next-generation mental wellness company that leverages emerging digital and medicinal technologies to achieve extraordinary patient outcomes. We developed our “patient graph” driven treatments by combining big data, machine learning, expertly-curated music streaming, a secure telehealth platform and at-home ketamine therapy to deliver a personalized and effective experience to our patients.
Braxia Scientific is a vertically integrated medical research company aiming to reduce the burden of mental disorders through novel ketamine and psychedelic compounds. Headed by world-leading depression researchers, Braxia Scientific operates a growing network of ketamine therapy clinics, and seeks to identify new IP-capable psychedelic derivatives, as well as educate the next generation of clinicians.
Combining neuroscientific research with plant ceremony and luxurious hospitality, Dimensions focuses on restorative well-being and transformational growth. Dimensions helps improve and transform lives by drawing on the restorative power of nature, spa rituals, remarkable cuisine, and psychedelic ceremonies in a growing international collection of safe, legal and luxurious settings.
MindBio Therapeutics is a multi-disciplinary psychedelics company with interests in microdosing clinical trials, digital mental health interventions, drug and formulation development and psychedelic assisted psychotherapies. Our aim is to discover novel ways to more effectively treat mental health conditions and change people’s lives in the process.
Red Light Holland is the only publicly-traded company in the world that produces, packages, and sells (through their wholly-owned subsidiary SR-wholesale, existing Smart Shops operators, and through www.iMicrodose.nl) premium brands of magic truffles to the legal, recreational market in the Netherlands while promoting responsible use via free tele-counseling, journaling app and interactive education with VR. RLH also sells functional mushroom products in the EU. As well, RLH produces and sells exotic mushrooms in Canada and the United States. We are suppliers, distributors, and brand-focused. Also, RLH’s R&D, Science and Innovation division: Scarlette Lillie, is in the early setup stages in St. Vincent and the Grenadines. Red Light Holland’s management and advisory members are comprised of a core group of highly skilled individuals with the wealth of combined knowledge and experience (relating to growing, mass-producing, compliance, distributing, marketing and managing, technology, etc.) necessary to propel Red Light Holland as a leader in this early-stage, emerging field.
MAPS is a leader in psychedelic research. Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
Nushama is a New York City based network of medically supervised psychedelic wellness centers providing sustained relief from depression, anxiety, chronic pain, addiction and trauma-induced mood disorders. With three locations including an immersive flagship, Nushama aims to provide access and foster community in a journey-inspired environment
Psilothera, Inc. is a pioneering Mental Healthcare& Life Sciences Company developing of proprietary Psilocybin based therapeutics.Psilothera’s battle tested leadership team will operate a Vertical Business Model that includes:Research & Development of 20 Species of Psilocybe Cubensis, Drug & Nutraceutical Development, Tele-Mental Healthcare Therapeutic Platform and psilocybin dispensary, Suicide Intervention & Prevention Programs and Psilothera Treatment Centers & Clinics.
Irwin Naturals is a functional mushroom, CBD and nutraceutical company founded in 1994 by Klee Irwin. Irwin Naturals Emergence will be a national chain of psychedelic mental health clinics focused on price accessibility for the masses. Irwin will be the world’s first household name brand to lend its trust-factor to the psychedelic mental health revolution. The launch is scheduled for Q1 of 2022.
Silver Sponsors
APEX’s objective is to be a leading pharmaceutical company bringing psychedelic drug product to market for patients suffering from post-traumatic disorder (PTSD), depression, addiction and other related mental health conditions. APEX’s Canadian clinical development program is focused on veterans and first responders – groups that are most affected by these disorders. The Company’s lead clinical candidate is a synthetic psilocin for the treatment of PTSD.
Mind Cure Health (“MINDCURE”) is a life sciences company focused on innovating and commercializing new ways to promote healing and improve mental health. The company is developing digital therapeutics technology and researching psychedelic compounds to support access to safe, evidence-based psychedelic-assisted therapies globally. Learn more at mindcure.com
Psychedelics Today is a leading digital media, education and training company in the field of psychedelic studies. Psychedelics Today has operations spanning journalism, broadcasting, training, conferences, and social media. Their podcast ‘Psychedelics Today’ has over 2.1 million downloads and their online training platform ‘Psychedelic Education Center’ has enrolled over 8,000 students.
Tabula Rasa Ventures is transforming mental health therapeutics through startup incubation and acceleration of high-growth psychedelic startups. We work hands-on with early-stage companies across psychedelics healthcare tech, infrastructure, and drug development to create value beyond capital deployment. We leverage our experience and network to help founders build the foundations necessary to achieve success in the burgeoning psychedelics field.
IMIO is dedicated to identify and refine the use of psychedelic molecules to better treat chronic pain. The approach is to combine known molecules with our proprietary BTLS drug delivery technology, enabling better penetration of molecules into the brain, reducing the therapeutic dose, providing a safer treatment while minimizing adverse effects.
Diamond Therapeutics’ mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. Diamond is focused on non-hallucinogenic treatments that hold potential for use across a broad patient cohort —maximizing the impact better drugs can have on global mental health. To learn more about Diamond’s Phase 1 trial with low-dose psilocybin, visit www.diamondthera.com
Journey Colab is a mission-driven for-profit psychedelic pharmaceutical startup developing treatments for addiction. Ten percent of our founding equity was irrevocably dedicated to the Journey Reciprocity Trust to share the value generated by our success with Indigenous stakeholders and to improve access to mental healthcare and conserve naturally occurring psychedelics.
Origin Therapeutics is an actively managed investment issuer focused on making equity investments in private, psychedelics-related companies. It leverages its management expertise, professional network, and due diligence process to identify companies that are innovating in the sector and supported by science, while also working with them to drive their growth.
Bronze Sponsors
MNP is a leading accounting, tax, and advisory firm with global practice. Their Psychedelics Industry Group is comprised of a team of dedicated professionals who understand the unique needs of the psychedelics industry. They take a proactive approach to ensure an organization is ahead of the curve of any accounting and taxation advancements. With a team that works in emerging and highly regulated sectors – MNP is well-positioned to help organizations optimize the opportunities that exist in the psychedelics industry.
DemeRx, Inc. is a Miami-based clinical stage pharmaceutical company focused on developing ibogaine and noribogaine for the treatment of OUD. DemeRx’s mission is to advance the development of potential treatments for OUD in order to prevent patient suffering, provide better treatment retention, and decrease illegal opioid use.
TheraPsil is a non-profit patient advocacy organization based in Canada, facilitating legal access to psilocybin therapy for patients in medical need. TheraPsil has a 4-pillar mission including compassionate access, public education, professional training and research. TheraPsil has submitted a proposal for draft regulations to Health Canada is currently advocating for medical psilocybin regulations so that patients in medical need can access psilocybin therapy in consultation with their healthcare provider.
Ehave, Inc. (EHVVF) is a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, independently or together, with psychedelics, medications, devices, and other therapies to optimize patient care and health outcomes.
Earth Resonance is Netherlands largest legal psychedelic microdosing company. We are taking the lead in the process of self-development in your personal and spiritual transformation based on microdosing with fresh Sclerotia which contains the bio-active compound Psilocybin. Together with our Earth Resonance Protocol and our microdosing therapists we guide you in every step of the way towards a happy and healthier life.
Psilera Inc. is a psychedelic-based biotechnology company developing its proprietary neuromodulator pipeline to target mental health disorders. With a proven and award-winning executive team, Psilera leverages research strengths from the pharmaceutical and cannabis industries to repurpose psychoactive natural products into patient-centric treatments. New formulations tailoring the therapeutic effects of DMT will improve treatment scalability and patient compliance further expanding addressable markets. Psilera’s technology platform (BRAIN) will identify next-generation compounds that have modified psychedelic and therapeutic effects in the areas of mood, cognitive, and substance use disorders.
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs. Tryp’s psilocybin-for-neuropsychiatric disorders, or PFN™, program is focused on the development of synthetic psilocybin as a new class of drug for the treatment of certain neuropsychiatric-based disorders.
Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. The Company aims to create a world class portfolio of psychedelic molecules that can become commercially viable drug candidates for both internal development and through future development partnerships.
Premium Exhibitor Sponsors
Ambria Capital is on a mission to empower early-stage companies, in the mental health and technology spaces, that have the ambition and ability to transform markets and make a difference in millions of lives. Ambria Capital has a portfolio of investments in psychedelic firms including atai Life Sciences, Cybin, Field Trip Health and many others.
Negev Capital is a psychedelic medical intervention investment fund with assets of USD$20+ million. The Company invests in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. They aim to support those early-stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP.
Iter Investments is a venture capital firm focused on supporting emerging companies within the ecosystem of developing innovative psychedelic-inspired therapeutics to address the underserved mental and behavioral health sectors. Our team represents the end-to-end psychedelic value chain, enabling unparalleled investment opportunity sourcing, diligence, and portfolio management.
Business Lounge Sponsor
Awakn Life Sciences is a biotechnology company with clinical operations, developing and delivering psychedelic therapeutics to better treat addiction. Awakn’s team consists of world leading chemists, scientists, psychiatrists, and psychologists who are developing and advancing the next generation of psychedelic drugs, therapies, and enabling technologies to treat addiction. Awakn will also deliver evidence-backed psychedelic therapies for addiction in clinics in the U.K. and Europe and through licensing partnerships globally.
VIP Lounge Sponsor
Levitee Labs is an emerging multidisciplinary integrative wellness company that’s redefining mental healthcare through a preventative, restorative, and transformative approach that includes evidence-based alternative medicines and novel psychedelic therapies. Through a vertically integrated and disciplined M&A model, the company introduces novel treatment modalities, with a key focus on the integration of evidence-based psychedelic medicines and therapies. This model addresses the burden of inefficiencies prevalent within current clinical treatments, particularly those available to underserved patient populations.
Speaker Room Sponsor
Zuber Lawler, one of the most selective law firms in the United States, represents clients throughout the world from offices in Austin, Chicago, Denver, Los Angeles, New York, Phoenix, and Silicon Valley. In addition to representing a long list of Fortune companies, as well as funds and government entities, Zuber Lawler has represented leading plant medicine companies for over 14 years, and practices at the cutting edge of psychedelics law. Zuber Lawler is uniquely situated to manage psychedelics IPOs; M&A and other deals; intellectual property; FDA and other regulatory work, and litigation. The firm’s attorney roster is stacked with bioscience PhDs and engineers. Its attorneys work in languages covering 90% of the world’s population.
Press Lounge Sponsor
Advancing Health & Wellness Through Clinical Research. Since 1997, KGK Science has played a key role in the natural health product industry by providing our clients with high-quality clinical research and regulatory expertise to bring safe and effective products to global markets. As a full-service premium contract research organization (CRO) supporting the nutraceutical, cannabis and hemp industries, KGK is one of the most reliable resources for brands looking for an experienced, trustworthy team of scientific researchers, consultants, and regulatory specialists to develop customized claim substantiation and path-to-market strategies.
After Dark Sponsors
Levitee Labs is an emerging multidisciplinary integrative wellness company that’s redefining mental healthcare through a preventative, restorative, and transformative approach that includes evidence-based alternative medicines and novel psychedelic therapies. Through a vertically integrated and disciplined M&A model, the company introduces novel treatment modalities, with a key focus on the integration of evidence-based psychedelic medicines and therapies. This model addresses the burden of inefficiencies prevalent within current clinical treatments, particularly those available to underserved patient populations.
Psychedelics are set to disrupt the multi billion dollar alcohol, tobacco, pharmaceutical, and health & wellness industries.There is an enormous opportunity for those early investors who are able to look past the historical negative stigma associated with many psychedelics. Psychedelic Invest is a resource for those looking to invest in the psychedelic industry.
VIP Drinks Sponsor
Psychedelic Water ® is the first legal psychedelic brand of its kind which offers a non-alcoholic, herbal supplement that delivers an uplifting and relaxed feeling perfect for work, play, and the adventures that await. Our mild mood-boosting product first splashed onto the scene selling out nationwide and offering millions the opportunity to loosen up and stimulate their senses. Our company is built on the ethos that psychedelics are more than something you consume. We believe in a psychedelic state of mind that is possessed by free thinkers, groundbreakers, risk takers and creators.
Awards Sponsor
Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 accounting firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 11,000+ clients through every step of the business life cycle.
Private Room Sponsors
Revitalist Lifestyle and Wellness Ltd. is a publicly traded (CSE: CALM) company, headquartered in Knoxville, Tennessee, with five clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided over 7,000 infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness.
Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. The Company aims to create a world class portfolio of psychedelic molecules that can become commercially viable drug candidates for both internal development and through future development partnerships.
Our mission is to develop targeted psychedelic therapeutics to address the unmet medical needs for women with chronic pain and hormone-related mood disorders, overlooked by modern medicine.
Psilothera is a pioneering mental health care company dedicated to creative, modern solutions to treat global healthcare concerns, including depression, anxiety, PTSD, eating disorders, addictions, Alzheimer’s, dementia, and more. We plan to deploy quantum technology to shorten the drug development time, which will give us an advantage over our competitors. With a focus on healing, hope, and compassion, we aim to change the paradigm of mental healthcare with their Psilocybin-based therapies.
JLS was formed to invest in the exciting intersection of science, technology and neurology, leveraging the enormous potential of plant-based and psychedelic medicines to heal illness and enhance wellness. We focus on the development of drugs for intractable mental and physical conditions and the enabling technology and tools that can accelerate and enhance the delivery of those therapies.
Standard Exhibitor Sponsors
Earth Resonance is Netherlands largest legal psychedelic microdosing company. We are taking the lead in the process of self-development in your personal and spiritual transformation based on microdosing with fresh Sclerotia which contains the bio-active compound Psilocybin. Together with our Earth Resonance Protocol and our microdosing therapists we guide you in every step of the way towards a happy and healthier life.
LongTermGevity Inc. (“LTG”) is a mental health therapeutics company focused on developing novel psychedelic-inspired medicines for treating various psychiatric and neurological conditions.
PsyDelta is the psychedelics-focused regulatory consulting firm, which wholly owned subsidiary of CannDelta Inc. PsyDelta is a team of nearly twenty Senior and Associate Consultants, each with PhD or MSc. PsyDelta was founded by former Health Canada Employees of the Medical Cannabis Program, the Office of Controlled Substances, the Health Products Branch and the Drug Analysis Lab.
Everyday Dose is an alternative to stimulants and highly caffeinated drinks. With less caffeine than matcha, we combine mushrooms, collagen, and nootropics to activate your DOSE.
Durée & Company, Inc. is an award-winning, full-service public relations, marketing and special events firm founded in 1999. Services include public relations, social media, marketing, digital marketing, content development, advertising, special events, branding, radio promotions, affiliate marketing and more. Durée & Company clients include well-known names in yachting, business, real estate, hospitality, travel, health and wellness, cannabis and psychedelics, art and culture, fashion, nonprofit organizations, cryptocurrency and technology, legal and professional services.
Our mission is to help people minimize the risks and fulfill the potential of their psychedelic experiences in ways such as providing compassionate, accessible, and culturally responsive peer support, educating the public, and furthering psychedelic research, while embracing practices that increase equity, power sharing, and belonging within the psychedelic movement.
MAPS is a leader in psychedelic research. Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
Cubed Biotech is a psilocybin extraction company developing solutions for depression, P.T.S.D., & anxiety. Cubed converts the potential energy of academic trials into the kinetic energy of commercialized medicine solutions.
Additional Sponsors
The Maya platform empowers psychedelic practitioners with technology they need to comprehensively map care journeys and improve health outcomes. Our global community of providers, participants, researchers, and analysts are working together to chart a knowledge base that informs safe and accessible psychedelic medicine practices
